Bacterial enumeration from mouse bladders showed that pro-hpAP reduced bacterial burden by 1.42 log at this lower dose, indicating pro-hpAP may be more potent in achieving partial protection against UTI (Fig. 7d). Here, ACP5 is linked to bacterial urinary tract infection.